Impact Factor 3.113 | CiteScore 3.03
More on impact ›
The section Nuclear Medicine aims to publish studies from the entire field, including the routine use of nuclear medicine tools for imaging and therapy, clinical trials, experimental molecular imaging and radionuclide therapy, radiobiology, radiopharmaceuticals, quantitative imaging and dosimetry.
The specialty section Nuclear Medicine is dedicated to the publication of results from preclinical research, translational research and clinical studies applied to nuclear medicine. Nuclear Medicine aims to publish studies from the entire field of nuclear medicine: results from the routine use of nuclear medicine tools for imaging and therapy, from clinical trials, experimental molecular imaging and radionuclide therapy in humans and animals, research on radiobiology, radiopharmaceuticals, quantitative imaging and dosimetry. The section Nuclear Medicine has a particular interest in:
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, Emerging Sources Citation Index, CLOCKSS
PMCID: all published articles receive a PMCID
Nuclear Medicine welcomes submissions of the following article types: Brief Research Report, Case Report, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Original Research, Perspective, Review, Study Protocol and Systematic Review.
All manuscripts must be submitted directly to the section Nuclear Medicine, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Nuclear Medicine will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Medicine.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact firstname.lastname@example.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact email@example.com